SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-14-007063
Filing Date
2014-12-15
Accepted
2014-12-15 13:34:51
Documents
11
Period of Report
2014-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neukf_10q.htm 10-Q 271649
2 CERTIFICATION neukf_ex311.htm EX-31.1 10130
3 CERTIFICATION neukf_ex312.htm EX-31.2 10001
4 CERTIFICATION neukf_ex321.htm EX-32.1 3958
5 CERTIFICATION neukf_ex322.htm EX-32.2 3587
  Complete submission text file 0001477932-14-007063.txt   2507298

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neukf-20141031.xml EX-101.INS 326921
7 XBRL TAXONOMY EXTENSION SCHEMA neukf-20141031.xsd EX-101.SCH 34536
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20141031_cal.xml EX-101.CAL 32826
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20141031_def.xml EX-101.DEF 54831
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20141031_lab.xml EX-101.LAB 151715
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20141031_pre.xml EX-101.PRE 122602
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 141285903
SIC: 2834 Pharmaceutical Preparations